GlaxoSmithKline may acquire Genzyme - MarketLine Financial Deals

GlaxoSmithKline may acquire Genzyme

GlaxoSmithKline may acquire Genzyme - MarketLine Financial Deals
GlaxoSmithKline may acquire Genzyme
Published Nov 14, 2010
3 pages — Published Nov 14, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Bloomberg, GlaxoSmithKline Plc, a UK-based research-based pharmaceutical and healthcare company, may acquire Genzyme Corporation, a US-based biotechnology company.

  
Source:
Document ID
MA38495_101116
Country
Country
Ticker
GSK=GB
Ticker
GENZ=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "GlaxoSmithKline may acquire Genzyme" Nov 14, 2010. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-may-acquire-Genzyme-2052-47279>
  
APA:
MarketLine Financial Deals. (2010). GlaxoSmithKline may acquire Genzyme Nov 14, 2010. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-may-acquire-Genzyme-2052-47279>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.